Evidence map›Paper›PMID 37845667›Full record

ArticleBMC urology2023

Longitudinal trend of urolithiasis incidence rates among world countries during past decades.

Nasrin Borumandnia, Payam Fattahi, Atefeh Talebi, Maryam Taheri, Mohammadamin Sabbagh Alvani, Mohammadreza Mafi Balani, Sadra Ashrafi, Hamid Alavimajd

Abstract read
In one paragraph

Article in BMC urology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nasrin BorumandniaUrology and Nephrology Research Centre, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Payam FattahiFaculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Atefeh TalebiBritish Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland.
Maryam TaheriUrology and Nephrology Research Centre, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mohammadamin Sabbagh AlvaniFaculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mohammadreza Mafi BalaniFaculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Sadra AshrafiStudent Research Committee, Chronic Kidney Disease Research Centre, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Hamid AlavimajdDepartment of Biostatistics, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. alavimajd@gmail.com.ORCID http://orcid.org/0000-0001-7772-2923

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThis study explores the trend of urolithiasis in various countries and categorizes the countries in terms of how their urolithiasis incidence rate has changed over time.

methodsThe incidence rate of urolithiasis in 204 countries from 1990 to 2019, extracted from the Global Burden of Disease study, has been analyzed.

resultsAccording to the results, all regions had experienced an increasing trend in urolithiasis rate, except for Eastern Europe, Central Europe, and Southeast Asia regions (decreasing rates of -71.4, -56.2, and -9.2 per 100000, respectively). Moreover, the Caribbean region had the highest increasing trend of urolithiasis rates, and Central Asia was in the next rank (increasing rate of 48.3 and 34.3 per 100,000, respectively, p-value < .05). Also, African regions revealed significant increasing trends over time (p-value < 0.05). The outstanding findings in cluster analysis showed that Afghanistan, Andorra, and Comoros had the most decreasing trend in urolithiasis rates over time (decreasing rate of -128.2 per 100000, p-value < .001). Cuba, Cyprus, Czechia, the Democratic People's Republic of Korea, Denmark, and Djibouti were in the next rank in terms of decreasing rate (decreasing rate of -92.3 per 100000, p-value < .001). In addition, urolithiasis rates in Congo, Eswatini, Gabon, and Grenada have the most increasing trend (increasing rate of 116.1 per 100000, p-value < .001).

conclusionThe trend of urolithiasis rates was significantly increased in most countries, and Congo, Eswatini, Gabon, and Grenada had the highest trend among others. Also, Afghanistan, Andorra, and Comoros revealed the most decreasing rates, and the trend has dropped remarkably in several other countries.

Indexed as

IncidenceEuropeHumansGBD studyGrowth mixture modelLongitudinal analysisUrolithiasis

Identifiers

PMID37845667
PMCPMC10577967

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.